Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H17N5O9P2 |
Molecular Weight | 425.2283 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]3O
InChI
InChIKey=OLCWZBFDIYXLAA-IOSLPCCCSA-N
InChI=1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1
α,β-methylene adenosine 5′-diphosphate (AOPCP, adenosine-5′-O-[(phosphonomethyl)phosphonic acid] or α,β-methylene-ADP) is an analog of adenosine 5′-diphosphate (ADP). It acts as a CD73/ecto-5′-nucleotidase inhibitor. Blocks ecto-5'-nucleotidase-mediated adenosine production by preventing the conversion of AMP to adenosine.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9039009
Curator's Comment: α,β-methylene-ADP is CNS active in animals. No human data available.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1075214 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26147331 |
197.0 nM [Ki] | ||
Target ID: GO:0002185 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6852021 |
|||
Target ID: EC 2.7.7.7 Sources: https://www.ncbi.nlm.nih.gov/pubmed/4521051 |
|||
Target ID: CHEMBL5957 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26147331 |
88.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
PHOSPHONIC ACID ANALOGS OF NUCLEOSIDE PHOSPHATES. 3. THE SYNTHESIS OF ADENOSINE-5'-METHYLENEDIPHOSPHONATE, A PHOSPHONIC ACID ANALOG OF ADENOSINE-5'-DIPHOSPHATE. | 1965 May |
|
Metabolic regulation of cytoplasmic DNA synthesis. | 1974 Jan |
|
Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion. | 2012 Jan |
|
Effect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation. | 2014 Dec |
|
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors. | 2015 Aug 13 |
Patents
Sample Use Guides
mice: α,β-methylene-ADP, was prepared at a concentration of 500 μg/100 μl of PBS, and animals were treated by gavage with APCP 20 mg/kg/day for 4 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15009686
50 uM α,β-methylene-ADP significantly reduced adenosine release from rat astrocytes but not neurons
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
223-194-0
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
2552302
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
92199
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
3768-14-7
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
DB03148
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
0T2A5439OE
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
DTXSID80958717
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
614641
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY | |||
|
0T2A5439OE
Created by
admin on Fri Dec 15 19:38:47 GMT 2023 , Edited by admin on Fri Dec 15 19:38:47 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD